These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7242013)

  • 1. Clostridium difficile antitoxin neutralization of cecal toxin(s) from guinea pigs with penicillin-associated colitis.
    Rehg JE; Pakes SP
    Lab Anim Sci; 1981 Apr; 31(2):156-60. PubMed ID: 7242013
    [No Abstract]   [Full Text] [Related]  

  • 2. Toxicity of cecal filtrates from guinea pigs with penicillin-associated colitis.
    Rehg JE; Yarbrough BA; Pakes SP
    Lab Anim Sci; 1980 Jun; 30(3):524-31. PubMed ID: 7431852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cecal toxin(s) from guinea pigs with clindamycin-associated colitis, neutralized by Clostridium sordellii antitoxin.
    Rehg JE
    Infect Immun; 1980 Feb; 27(2):387-90. PubMed ID: 7380535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of Clostridium difficile toxin in guinea pigs with penicillin-associated colitis.
    Rothman SW
    Med Microbiol Immunol; 1981; 169(3):187-96. PubMed ID: 7254132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implication of Clostridium difficile and Clostridium perfringens iota toxins in experimental lincomycin-associated colitis of rabbits.
    Rehg JE; Pakes SP
    Lab Anim Sci; 1982 Jun; 32(3):253-7. PubMed ID: 6285077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clostridium difficile-associated cecitis in guinea pigs exposed to penicillin.
    Lowe BR; Fox JG; Bartlett JG
    Am J Vet Res; 1980 Aug; 41(8):1277-9. PubMed ID: 6969561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production and properties of theta-toxin of Clostridium perfringens with special reference to lethal activity.
    Soda S; Ito A; Yamamoto A
    Jpn J Med Sci Biol; 1976 Dec; 29(6):335-49. PubMed ID: 192930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralization of Clostridium difficile toxin by Clostridium sordellii antitoxins.
    Chang TW; Gorbach SL; Bartlett JB
    Infect Immun; 1978 Nov; 22(2):418-22. PubMed ID: 730363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of antitoxins to two toxins of Clostridium difficile and immunological comparison of the toxins by cross-neutralization studies.
    Libby JM; Wilkins TD
    Infect Immun; 1982 Jan; 35(1):374-6. PubMed ID: 6172384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variation and cross-reactivity of Clostridium septicum alpha-toxin.
    Amimoto K; Sasaki Y; Fukuyama S; Tamura Y
    Vet Microbiol; 2006 Apr; 114(1-2):51-9. PubMed ID: 16337096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The use of the toxin binding inhibition test for potency testing of Clostridium novyi type B alpha toxoid vaccines].
    Luick K; Gottschaldt J; Schulze F; Werner E; Erler W; Borrmann E
    Dtsch Tierarztl Wochenschr; 2002 Apr; 109(4):178-82. PubMed ID: 11998370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of clindamycin-induced colitis in hamsters by Clostridium sordellii antitoxin.
    Allo M; Silva J; Fekety R; Rifkin GD; Waskin H
    Gastroenterology; 1979 Feb; 76(2):351-5. PubMed ID: 759263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of clostridial toxin in the pathogenesis of clindamycin colitis in rabbits.
    LaMont JT; Sonnenblick EB; Rothman S
    Gastroenterology; 1979 Feb; 76(2):356-61. PubMed ID: 759264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on Clostridium oedematiens antitoxin with special attention to anti-lethal and anti-edematous activities.
    Izumi N; Tokumaru Y; Amano T; Niiro M; Kondo H
    Jpn J Med Sci Biol; 1979 Apr; 32(2):123-4. PubMed ID: 541870
    [No Abstract]   [Full Text] [Related]  

  • 15. Clostridium sordellii infection and toxin neutralization.
    Grimwood K; Evans GA; Govender ST; Woods DE
    Pediatr Infect Dis J; 1990 Aug; 9(8):582-5. PubMed ID: 2235175
    [No Abstract]   [Full Text] [Related]  

  • 16. Production of Clostridium difficile antitoxin.
    Ehrich M; Van Tassell RL; Libby JM; Wilkins TD
    Infect Immun; 1980 Jun; 28(3):1041-3. PubMed ID: 7399686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The protective effect of Clostridium novyi type B alpha-toxoid against challenge with spores in guinea pigs.
    Amimoto K; Sasaki O; Isogai M; Kitajima T; Oishi E; Okada N; Yasuhara H
    J Vet Med Sci; 1998 Jun; 60(6):681-5. PubMed ID: 9673937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clostridium difficile toxins and enterococcal translocation in vivo and in vitro.
    Feltis BA; Garni RM; Wells CL
    J Surg Res; 2001 May; 97(1):97-102. PubMed ID: 11319888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An international survey of clostridial sera and vaccines.
    Davidson I
    Dev Biol Stand; 1976; 32():3-14. PubMed ID: 187508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of iota-like toxin and Clostridium spiroforme with both spontaneous and antibiotic-associated diarrhea and colitis in rabbits.
    Borriello SP; Carman RJ
    J Clin Microbiol; 1983 Mar; 17(3):414-8. PubMed ID: 6841578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.